A 35-year-old man from rural Maharashtra presents to the emergency department 18 hours after consuming wild mushrooms foraged from his garden. He reports severe vomiting and profuse watery diarrhea that began 8 hours post-ingestion. Abdominal examination is unremarkable. Liver function tests are currently normal. The structure marked **B** in the diagram is the primary molecular target of the toxin responsible for this patient's presentation. Which of the following best describes the mechanism by which this toxin causes hepatocellular injury in amanita poisoning?

Explanation

## Why "Tight binding to RNA Polymerase II, halting mRNA synthesis and leading to depletion of essential proteins in hepatocytes with high transcription rates" is right The structure marked **B** is RNA Polymerase II, which synthesizes all eukaryotic mRNA and most snRNAs. α-Amanitin, the cyclopeptide toxin from *Amanita phalloides* ("death cap" mushroom), binds tightly and irreversibly to RNA Pol II, blocking the translocation step and halting mRNA synthesis. Hepatocytes are particularly vulnerable because they have exceptionally high transcription rates (producing plasma proteins, enzymes, clotting factors). When mRNA synthesis stops, these essential proteins become depleted, leading to hepatic dysfunction. The delayed GI phase (6–24 hours) and subsequent deceptive latent phase (24–72 hours) are characteristic of amatoxin poisoning and distinguish it from typical food poisoning (which occurs < 4 hours). This mechanism is the basis for the clinical course described in Harper 32e Ch 36 and Robbins 10e Ch 9. ## Why each distractor is wrong - **Irreversible inhibition of the β-subunit of bacterial RNA polymerase**: This describes the mechanism of rifampin, not α-amanitin. Rifampin targets bacterial RNA polymerase (structure **D**), not eukaryotic RNA Pol II. Additionally, hepatocytes do not contain bacterial RNA polymerase. - **Competitive inhibition of hepatocyte membrane uptake of the toxin**: While silibinin (milk thistle, IV Legalon SIL) is indeed used as a treatment for amanita poisoning by competitively inhibiting hepatocyte uptake of α-amanitin, this describes a *therapeutic intervention*, not the primary mechanism of toxin-induced injury. The toxin must first enter the cell and bind RNA Pol II to cause damage. - **Inhibition of tRNA synthetases, resulting in impaired translation and protein synthesis collapse**: This is not the mechanism of α-amanitin. tRNA synthetase inhibition would affect translation, but α-amanitin acts at the transcription level (blocking mRNA synthesis), not translation. This distractor confuses two distinct steps of gene expression. **High-Yield:** α-Amanitin is the EXCLUSIVE inhibitor of eukaryotic RNA Pol II; hepatocytes die because they cannot synthesize mRNA for essential proteins; the 6–24 hour delay before GI symptoms is a diagnostic clue distinguishing amatoxin from typical food poisoning. [cite: Harper 32e Ch 36; Robbins 10e Ch 9]